LiPlasome Pharma |
|
||
| The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years. | |||
| Address: | Technical University of Denmark, Building 207 | ||
| City: | Lybgby | ||
| State/Province: | |||
| Postcode: | 2800 | ||
| Country: | Denmark | ||
